Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-3-23
|
pubmed:abstractText |
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogenesis imperfecta (type II B). Dermal cultured fibroblasts from the proband were shown to produce both normal and heavily overmodified type-I collagen. The mutation introduced a local conformational perturbation, which causes abnormal exposure of arginine residues; the triple helical domain was susceptible to trypsin digestion even at 30 degrees C. The chains bearing the point mutation were poorly secreted and short-term pulse experiments showed that the extensive intracellular retention of mutant trimers also impaired the secretion of normal chains. The molecular defect was localized in a COL1A1 allele by cloning and sequencing a cDNA region corresponding to the CB6 peptide. A G to C transversion which causes the substitution in the triple helical region of Gly910 with alanine was found. The mutation also causes the disappearance of a MspI-recognition site at nucleotide 3263 of the pro alpha 1 (I) coding sequence. Restriction analysis, along with the biochemical screening of collagens, allowed us to perform prenatal diagnosis on cells from chorionic-villus sampling and to exclude the recurrence of the mutation in the sibling.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alanine,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Cyanogen Bromide,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonuclease HpaII,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxyribonucleases, Type II...,
http://linkedlifedata.com/resource/pubmed/chemical/Glycine,
http://linkedlifedata.com/resource/pubmed/chemical/Trypsin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
211
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
415-9
|
pubmed:dateRevised |
2007-7-23
|
pubmed:meshHeading |
pubmed-meshheading:7679635-Alanine,
pubmed-meshheading:7679635-Collagen,
pubmed-meshheading:7679635-Cyanogen Bromide,
pubmed-meshheading:7679635-Deoxyribonuclease HpaII,
pubmed-meshheading:7679635-Deoxyribonucleases, Type II Site-Specific,
pubmed-meshheading:7679635-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:7679635-Female,
pubmed-meshheading:7679635-Fibroblasts,
pubmed-meshheading:7679635-Glycine,
pubmed-meshheading:7679635-Humans,
pubmed-meshheading:7679635-Infant, Newborn,
pubmed-meshheading:7679635-Osteogenesis Imperfecta,
pubmed-meshheading:7679635-Peptide Mapping,
pubmed-meshheading:7679635-Point Mutation,
pubmed-meshheading:7679635-Sequence Analysis, DNA,
pubmed-meshheading:7679635-Trypsin
|
pubmed:year |
1993
|
pubmed:articleTitle |
Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain.
|
pubmed:affiliation |
Dipartimento di Biochimica, Università di Pavia, Italy.
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|